Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Glioblastoma Therapy: Past, Present and Future
2024 Standout
28 intermediate papers

Works of H. I. Robins being referenced

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
2014
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
H. I. Robins 275 133 87 228 20 556
Eduard B. Dinca 278 95 105 244 17 642
Benedikte Hasselbalch 387 133 59 151 22 476
Christine Lu‐Emerson 229 97 46 163 18 537
Iyad Alnahhas 232 113 62 120 34 461
Cathy Brewer 353 163 114 134 15 522
Ardi Pambuku 435 163 45 168 27 620
Kenneth Aldape 317 133 32 283 20 634
Macarena I. de la Fuente 282 76 39 145 33 480
Mahshid Saleh 286 80 87 200 22 637
Jun‐ichiro Kuroda 138 63 112 266 33 602

All Works

Loading papers...

Rankless by CCL
2026